March Quarter free cash flow of $1.6M x 4 = $6.4M (annualized) x 20 for valuation of $128M or $0.99 per share.
June Quarter free cash flow guesstimate $2.5M x 4 = $10.0M annualized x 20 for valuation of $200M or $1.54 per share.
September Quarter free cash flow $3.5M x 4 = $14.0M x 20 for valuation of $280M or $2.15 per share.
Quarterly (global) operating and investment expense of $4.0M established and stablized for last 3 quarters. This thing is going BIG.
- Forums
- ASX - By Stock
- BIG
- 9 month share price target is +$2.00 share
9 month share price target is +$2.00 share
-
-
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online